1,028 research outputs found
Muon and electron and lepton masses in flavor models
The stringent experimental bound on is compatible
with a simultaneous and sizable new physics contribution to the electron and
muon anomalous magnetic moments (), only if we
assume a non-trivial flavor structure of the dipole operator coefficients. We
propose a mechanism in which the realization of the correction is
manifestly related to the mass generation through a flavor symmetry. A
radiative flavon correction to the fermion mass gives a contribution to the
anomalous magnetic moment. In this framework, we introduce a chiral enhancement
from a non-trivial quartic coupling of the scalar potential.
We show that the muon and electron anomalies can be simultaneously explained in
a vast region of the parameter space with predicted vector-like mediators of
masses as large as ~TeV.Comment: 18 pages, 3 figures, 2 table
Implications of the Muon g-2 result on the flavour structure of the lepton mass matrix
The confirmation of the discrepancy with the Standard Model predictions in
the anomalous magnetic moment by the Muon g-2 experiment at Fermilab points to
a low scale of new physics. Flavour symmetries broken at low energies can
account for this discrepancy but these models are much more restricted, as they
would also generate off-diagonal entries in the dipole moment matrix.
Therefore, if we assume that the observed discrepancy in the muon is
explained by the contributions of a low-energy flavor symmetry, lepton flavour
violating processes can constrain the structure of the lepton mass matrices and
therefore the flavour symmetries themselves predicting these structures. We
apply these ideas to several discrete flavour symmetries popular in the
leptonic sector, such as , , and .Comment: 21 pages; v3: comments added, typos corrected, version accepted for
publication in EPJ
El comercio azucarero de La Española en el siglo XI/I. Presión rnonopolÃstica y alternativas locales.
Sin resume
El trigo en la ciudad de México. Industria y comercio de un cultivo importado (1521 - 1564)
Sin resume
Estudio de la biocompatibilidad in vitro de formulaciones acrÃlicas autocurables portadoras de bisfosfonatos de nueva sÃntesis
En este trabajo se presenta el estudio de la biocompatibilidad in vitro, empleando cultivos celulares de fibroblastos embrionarios humanos, de tres sistemas acrÃlicos de liberación controlada de bisfosfonatos (BFs). Estos sistemas, basados en metacrilato de metilo (MMA), metacrilato de vitamina E (MVE) y trietilenglicol dimetacrilato (TEGDMA), han sido diseñados para su aplicación en el tratamiento de enfermedades caracterizadas por una elevada resorción osteoclástica. En su preparación se ha empleado un BP comercializado (alendronato; ALN) y dos de nueva sÃntesis, pertenecientes a la segunda y tercera generaciones, el ácido 1-hidroxi-2-[4-aminofenil]etano-1,1-difosfónico (APBP) y el ácido 1-hidroxi-2-[3-indolil]etano-1,1-difosfónico (IBP), respectivamente. La citotoxicidad de MVE ha sido notablemente inferior a la medida para TEGDMA. La citotoxicidad de APBP e IBP se ha comparado con la de ALN, obteniéndose unos valores para la concentración IC50, de15,56, 9,86 y 6,25 mmol/l para APBP, ALN e IBP, respectivamente. Los niveles de citotoxicidad liberada han sido superiores para la formulación portadora de ALN, situándose a continuación los cementos cargados con IBP y APBP. Cuando los cultivos se han establecido sobre la superficie de las formulaciones, se han detectado unos niveles de proliferación celular y adhesión superiores para los sistemas de liberación de IBP y APBP, siendo además inferior en estos casos la mortalidad celular.This paper reports the in vitro biocompatibility study, using human embryonic fibroblast cultures, of three acrylic systems for controlled release of bisphosphonates (BFs). These systems, that are based on methyl methacrylate (MMA), vitamin E methacrylate (MVE) and triethyleneglycol dimethacrylate (TEGDMA), have been designed for its application in the treatment of pathologies characterized by a high osteoclastic resorption. A commercial BP (alendronate; ALN) and two novel BPs, belonging to the second and third generations, 1-hydroxy-2-[4-aminophenyl]ethane-1,1-diphosphonic acid (APBP) and 1-hydroxy-2-[3-indolyl]ethane-1,1-diphosphonic acid (IBP), respectively, have been used in their preparation. The cytotoxicity of MVE has been notably lower than that measured for TEGDMA. Cytotoxicity of APBP and IBP was evaluated along with that of ALN, and the following values of the IC50, concentration were obtained for APBP, ALN and IBP respectively: 15.56, 9.86 and 6.25 mmol/l. The cytotoxicity levels obtained from the extracts of the cured systems were higher for the formulation containing ALN, followed by the cements loaded with IBP and APBP. When the cultures were seeded directly on the formulations surface, higher levels of cellular proliferation and adhesion were obtained for the systems containing IBP and APBP, the cellular mortality being also inferior in these cases
Xylotrechus arvicola (Olivier) (Coleoptera, Cerambycidae), a new impacting pest on Spanish vineyards
Research NoteInfestation caused by Xylotrechus arvicola (Olivier) (Coleoptera, Cerambycidae) is becoming a new sanitary problem in some Spanish vine-producing areas. Symptoms caused by the pest, the identification of 7 associated wood fungal species living in galleries excavated by larvae, some data about the evolution of the infestation during 8 years in the same plot and the different levels of susceptibility exhibited by three grape varieties are presented in this paper
Suitability of salivary leucocytes to assess DNA repair ability in human biomonitoring studies by the challenge-comet assay
The challenge-comet assay is a simple but effective approach that provides a quantitative and functional determination of DNA repair ability, and allows to monitor the kinetics of repair process. Peripheral blood mononuclear cells (PBMC) are the cells most frequently employed in human biomonitoring studies using the challenge-comet assay, but having a validated alternative of non-invasive biomatrix would be highly convenient for certain population groups and circumstances. The objective of this study was to validate the use of salivary leucocytes in the challenge-comet assay. Leucocytes were isolated from saliva samples and challenged (either in fresh or after cryopreservation) with three genotoxic agents acting by different action mechanisms: bleomycin, methyl methanesulfonate, and ultraviolet radiation. Comet assay was performed just after treatment and at other three additional time points, in order to study repair kinetics. The results obtained demonstrated that saliva leucocytes were as suitable as PBMC for assessing DNA damage of different nature that was efficiently repaired over the evaluated time points, even after 5 months of cryopreservation (after a 24 h stimulation with PHA). Furthermore, a new parameter to determine the efficacy of the repair process, independent of the initial amount of damage induced, is proposed, and recommendations to perform the challenge-comet assay with salivary leucocytes depending on the type of DNA repair to be assessed are suggested. Validation studies are needed to verify whether the method is reproducible and results reliable and comparable among laboratories and studies. © 2022 The AuthorsFunding text 1: This work was funded by the Spanish Ministry of Science and Innovation : MCIN/AEI/10.13039/501100011033 (Grants PID2020-113788RB-I00 and PID2020-114908 GA-I00 ), NanoBioBarriers project (PTDC/MED-TOX/31162/2017), Xunta de Galicia (ED431B 2022/16), co-financed by the Operational Program for Competitiveness and Internationalization (POCI) through European Regional Development Funds ( FEDER / FNR ), Spanish Ministry of Education, Culture and Sport [ BEAGAL18/00142 to V.V.], and Spanish Ministry of Economy and Competitiveness , co-financed by the European Social Fund [ RYC-2015-18394 to L.L,-L,]. Funding for open access charge: Universidade da Coruña/CISUG. ; Funding text 2: This work was funded by the Spanish Ministry of Science and Innovation: MCIN/AEI/10.13039/501100011033 (Grants PID2020-113788RB-I00 and PID2020-114908 GA-I00), NanoBioBarriers project (PTDC/MED-TOX/31162/2017), Xunta de Galicia (ED431B 2022/16), co-financed by the Operational Program for Competitiveness and Internationalization (POCI) through European Regional Development Funds (FEDER/FNR), Spanish Ministry of Education, Culture and Sport [BEAGAL18/00142 to V.V.], and Spanish Ministry of Economy and Competitiveness, co-financed by the European Social Fund [RYC-2015-18394 to L.L,-L,]. Funding for open access charge: Universidade da Coruña/CISUG
- …